⬤─⬤─⬤ ╲⬤ KATSULA PHARMA
RESEARCH CHEMICALS FAQ DISCLAIMER |
KATSULA PHARMA is a Securities Market Maker(DSMM) in the parallel pharmaceutical market.
These are currently with a refused market authorization status.
Our main objective is to bring back to the secondary pharmaceutical market new medications, APIs and FDCs that have an status not approved for human use or have no medicinal value according to EMA Scientific Committees.
Contacts
admin@katsulapharma.com
Frontend for EMA Regulatory staff